Researchers should , however , be very cautious during the implementation of pharmacogenomic studies , because there is a large chance of generating false-positive results alongside screening categories . Family-based approaches to pharmacogenomic studies are not that informative because it will only complicate analysis due to the addition of patterns of horizontal inheritance . As research in pharmacogenetics strengthens , more tests for robustness and reliability of data should be performed , in to apply the findings in a clinical setting . The amount of variance in each...











SUBJECTS

